Vyne Therapeutics Inc (VYNE) — Financial Flexibility Index
Vyne Therapeutics Inc (VYNE) has a Financial Flexibility Index of -1.57x as of December 2025. Free cash flow of $-3.76 Million (operating CF $-3.76 Million minus capex $0.00) represents -2% of total liabilities ($2.40 Million). Check VYNE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vyne Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Vyne Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see VYNE cash flow conversion.
Annual Financial Flexibility Index for Vyne Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Vyne Therapeutics Inc. Explore VYNE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.83x | $-33.12 Million | $-33.12 Million | $2.40 Million | ▼ -505.4% |
| 2024 | -2.28x | $-33.85 Million | $-33.97 Million | $14.82 Million | ▲ +19.3% |
| 2023 | -2.83x | $-25.34 Million | $-25.34 Million | $8.95 Million | ▲ +7.3% |
| 2022 | -3.06x | $-29.20 Million | $-29.20 Million | $9.56 Million | ▲ +0.2% |
| 2021 | -3.06x | $-56.37 Million | $-56.37 Million | $18.41 Million | ▼ -25.7% |
| 2020 | -2.44x | $-136.97 Million | $-137.08 Million | $56.25 Million | ▲ +60.1% |
| 2019 | -6.11x | $-65.09 Million | $-65.10 Million | $10.66 Million | ▼ -10.9% |
| 2018 | -5.51x | $-52.59 Million | $-52.73 Million | $9.55 Million | ▼ -2317.7% |
| 2017 | -0.23x | $-28.22 Million | $-28.25 Million | $123.90 Million | ▼ -620.5% |
| 2016 | -0.03x | $-2.26 Million | $-2.29 Million | $71.49 Million | ▲ +54.8% |
| 2015 | -0.07x | $-4.18 Million | $-4.18 Million | $59.84 Million | — |